Naltrexone/Bupropion, Liraglutide, or Semaglutide as Adjuvant Therapy After Metabolic and Bariatric Surgery: An Observational Study

Documenti analoghi

• Joint Pain Outcomes After Metabolic and Bariatric Surgery in Patients With and Without Hypermobility
  di: Elke Schubert‐Hjalmarsson, et al.
  Pubblicazione: (2026)
• A Longitudinal Mediation Analysis of Quality of Life After Metabolic and Bariatric Surgery
  di: Maria Rosaria Magurano, et al.
  Pubblicazione: (2026)
• Long‐Term Experience of Undergoing Metabolic and Bariatric Surgery as an Adolescent
  di: Malin Örn, et al.
  Pubblicazione: (2025)
• Motivators and Barriers to Seeking Metabolic and Bariatric Surgery Among Adolescents: A Qualitative Study
  di: Marlyn A. Allicock, et al.
  Pubblicazione: (2025)
• The Interplay Between Social Factors and Metabolic Bariatric Surgery Outcomes—A 5‐Year Prospective Study
  di: Uta Sailer, et al.
  Pubblicazione: (2025)